asia healthspace

Today, I stumbled upon a new, very interesting blog concept started by Adam Marcus and Ivan Oransky, addressing scientific journalism and its accuracy: Retraction Watch. In the pursuit of accountability you have to love the web enabling blogs and organizations like this, Wikileaks, and other independent forms of investigative journalism and expression. Old school media [...]

Ever since I was a young lad of 17 years age (let’s just say at least 2 decades have passed!) I have been feverishly following the world of politics and economics. No journal or publication has informed and influenced me more than the Economist. Growing up in a small blue-collar Canadian town (Sarnia, Ontario), one [...]

The top 3 suppliers in the ophthalmic markets in APAC are Santen, Pfizer and Alcon. These top suppliers usually compete in the premium prescriptive market with their innovative product offerings, while OTC products only contribute a minor percentage to the total sales revenue. Sales in the prescriptive hospital segment are supported by dedicated teams of [...]

The following general insights were provided by Ivy Teh when interviewed for a recent press release. 1. Is there a general way to characterize the difference between Asia-Pacific-style pricing and reimbursement policies as compared to US? Firstly, one must understand that the Asia Pacific region is a highly diverse one. There are countries ranging from [...]

HAT TIP to Damjan Denoble of Asia Health Care Blog in revealing this fabulous initiative. Asia Catalyst is an NGO with the professed mission of partnering with “activists in Asia to inspire, create and launch innovative, self-sustaining programs and organizations that advance human rights, social justice and environmental protection. We link up Asian community leaders, [...]

In a constant effort to innovate our beloved healthcare space, we at asiahealthspace have designed a new suite of products promising to add substantial value to the health of society. The first is the PDS . The PDS is otherwise known as the Patient Death or Disability Swap. This instrument allows physicians to purchase life [...]

Yesterday I had the pleasure of having lunch with Bloomberg’s Asia Health and Science correspondent, Simeon Bennett. He was kind enough to share with me a very interesting but alarming piece that he researched for Bloomberg back in May of 2009. It is a insightful article which exposes the seamy underbelly of pharmaceutical capitalism in [...]

In the short article “Wild East or Scientific Feast?” published in the January 14, 2010 issue of The Economist, the author highlights the flourish in stem cell science in China as measured by papers published in respected, internationally peer-reviewed journals. In contrast to such solid and honest scientific advances, some of which impact my own [...]

Well, I apologize for the lack of blog postings recently but I have just returned from a very interesting business trip/meeting in Istanbul hosted by a very interesting company, United BioSource Corporation. UBC is a global medical and scientific affairs organization that partners with manufacturers of biopharmaceuticals and medical devices to develop and commercialize their [...]

I must say that I am most comfortable with a small handful of good friends; those I can chill with over a cold beer. Thus I was quite surprised to observe myself INITIALLY embrace social network sites such as Facebook and Twitter. Quickly my “friends” list shot up to a bunch or so, many of [...]